Testing of the OMERACT 8 draft validation criteria for a soluble biomarker reflecting structural damage in rheumatoid arthritis: A systematic literature search on 5 candidate biomarkers Review uri icon

Overview

MeSH Major

  • Arthritis, Rheumatoid
  • Biomarkers
  • Consensus Development Conferences as Topic
  • Joints

abstract

  • Evidence in support of any of the 5 tested biomarkers (MMP-3, CTX-I, CTX-II, OPG, RANKL) was inadequate to allow their substitution for radiographic endpoints in RA. Three of the criteria in the draft criteria set might not be required, but few omissions were identified.

publication date

  • August 2009

Research

keywords

  • Review

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3899/jrheum.090262

PubMed ID

  • 19671812

Additional Document Info

start page

  • 1769

end page

  • 84

volume

  • 36

number

  • 8